rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
17
|
pubmed:dateCreated |
2009-9-2
|
pubmed:abstractText |
We previously reported that protein kinase A type I (PKA(RIalpha)) overexpression was predictive of outcome in prostate cancer patients treated with radiotherapy (RT) +/- short-term androgen deprivation (STAD) on Radiation Therapy Oncology Group (RTOG) protocol 86-10. Here, we attempt to verify our prior findings and test the hypothesis that the relationship of the length of AD to patient outcome is affected by PKA(RIalpha) overexpression.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5478-84
|
pubmed:dateRevised |
2011-6-17
|
pubmed:meshHeading |
pubmed-meshheading:19706804-Adult,
pubmed-meshheading:19706804-Aged,
pubmed-meshheading:19706804-Aged, 80 and over,
pubmed-meshheading:19706804-Androgen Antagonists,
pubmed-meshheading:19706804-Cohort Studies,
pubmed-meshheading:19706804-Combined Modality Therapy,
pubmed-meshheading:19706804-Cyclic AMP-Dependent Protein Kinase Type I,
pubmed-meshheading:19706804-Humans,
pubmed-meshheading:19706804-Male,
pubmed-meshheading:19706804-Middle Aged,
pubmed-meshheading:19706804-Multivariate Analysis,
pubmed-meshheading:19706804-Proportional Hazards Models,
pubmed-meshheading:19706804-Prostatic Neoplasms,
pubmed-meshheading:19706804-Radiotherapy Dosage,
pubmed-meshheading:19706804-Treatment Outcome,
pubmed-meshheading:19706804-Tumor Markers, Biological
|
pubmed:year |
2009
|
pubmed:articleTitle |
The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.
|
pubmed:affiliation |
Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida 33136, USA. apollack@med.miami.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III,
Research Support, N.I.H., Extramural
|